ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SN. Smith & Nephew Plc

978.00
-5.40 (-0.55%)
Last Updated: 08:15:09
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.40 -0.55% 978.00 977.20 978.00 982.60 975.00 982.60 63,189 08:15:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Ortho,prosth,surg Appl,suply 5.55B 263M 0.3011 32.66 8.59B
Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 983.40p. Over the last year, Smith & Nephew shares have traded in a share price range of 887.00p to 1,316.00p.

Smith & Nephew currently has 873,398,889 shares in issue. The market capitalisation of Smith & Nephew is £8.59 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 32.66.

Smith & Nephew Share Discussion Threads

Showing 526 to 549 of 1325 messages
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older
DateSubjectAuthorDiscuss
14/11/2011
10:00
A sitting duck imo.
philo124
14/11/2011
09:57
Keeps spiking up on Friday and today. Quality in an unstable market or are those bid rumours back up and running?

ArtN

artnouveau
09/11/2011
13:43
anyone else think it's going to be a big challenge to switch their
major manufacturing operation to lower cost countries - all while
maintaining their excellent quality and service?.

Its what I do and I can tell you that while all the consultants say it can be done its a nightmare.

M

magli
07/11/2011
15:34
Suprised by the lack of discussion here on the update.

Anyone else think it's going to be a big challenge to switch their
major manufacturing operation to lower cost countries - all while
maintaining their excellent quality and service?.

essentialinvestor
04/11/2011
09:48
Agree again, the balance sheet is lean and S&N could be the hunter and not the hunted.

ArtN

artnouveau
04/11/2011
09:42
Fair enough Art, however remember that SN. may be the buyer
rather than a target, and that could mean a major rights issue.
Two sides of the coin - hopefully the CEO would not be tempted into
a major acquisition.

The margin decline in such a short period of time is hugely disappointing imv.

essentialinvestor
04/11/2011
09:34
I don't disagree with your view EI but there's synergies to be had in a competitive market and as we all know M&A activity will accelerate next year. I wouldn't mind betting the likes of Smith & Nephew, Cobham and Lonmin aren't involved.

S&N's low debt will also attract private equity let alone any other suitors...

ArtN

artnouveau
04/11/2011
09:27
I listened to the last webcast with the CEO a couple of times,
and he stressed that the strategic review was not necessarily about
cost cutting, just more focussed working practices ...

within just a few weeks of that interview we have this mornings statement.

What guarantee is there that margins will improve so dramatically in Q4?,
as just a few weeks ago that decline was not anticipated.

I also have some doubts that SN. will be able to maintain anything like
current margins in emerging economies where they want to grow.

Too much opticism here, all imv, dyor as always.

essentialinvestor
04/11/2011
09:16
Major regulatory hurdles to any bid and J&J went elsewhere, having
just completed a huge acquisition.

The recent weakness in the share price has been borne out by today's results imv.

essentialinvestor
04/11/2011
08:56
revenue up but margin pressure explains why the city are marking them down a bit. Yet they remain a quality growth play and the m&a chance remains. I think the city could do with another deal after losing £40m+ of fees on the aborted g4s deal last week!
edwardt
04/11/2011
08:16
Certainly a possible bid situation here, S&N's debt down to below $100mn from $600mn. Looks a quality sitting duck to me. No doubt Biomet and Stryker will be mentioned again.

ArtN

artnouveau
04/11/2011
08:08
I don't think so; the chances of a bid at 700p being made & accepted have increased imo.
philo124
04/11/2011
07:30
Has to be said, stonking Q3 results...
artnouveau
02/11/2011
08:58
The Stryker share price fell heavily yesterday.
SN. looks good longer term value to me,
however the yeild is not supportive when so many are looking for income.

essentialinvestor
20/10/2011
09:43
good read across from the strycker results last night in the staes, should be supportive for shares..
edwardt
31/8/2011
08:34
CS have a valuation of 900p.
philo124
31/8/2011
08:31
looks like stryker bid rumours are doing the rounds again, hence strong share price
edwardt
05/8/2011
20:29
hmm..maybe 500
badtime
04/8/2011
20:29
Hmmm might b tempted at 550
badtime
03/8/2011
19:35
BELOW £6, TOTALLY IRRATIONAL.
philo124
11/5/2011
13:45
Smith & Nephew upgraded to buy from reduce at Kepler, TP 760p vs 750p.
nellie1973
05/5/2011
18:49
Yep, in SIPP , no hurry.
philo124
05/5/2011
15:50
Yeah, 1st quarter results out earlier as well. Quite a steady share this one with a chance of a bid but very good growth prospects too. One to tuck away and keep in the SIPP with the likes of SOCO & M&S me feels. ArtN
artnouveau
05/5/2011
15:43
Broker upgrade to buy target 720p
nellie1973
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older

Your Recent History

Delayed Upgrade Clock